(Q44532758)

3 December 2017

title

Neurohormones and oxidative stress in nonischemic cardiomyopathy: relationship to survival and the effect of treatment with amlodipine (English)

1 reference

3 December 2017

H C Wijeysundera

1

1 reference

3 December 2017

M S Hansen

2

1 reference

3 December 2017

E Stanton

3

1 reference

3 December 2017

A S Cropp

4

1 reference

3 December 2017

C Hall

5

1 reference

3 December 2017

N S Dhalla

6

1 reference

3 December 2017

J Ghali

7

1 reference

3 December 2017

J L Rouleau

8

1 reference

3 December 2017

PRAISE II Investigators

9

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

3 December 2017

published in

American Heart Journal

1 reference

3 December 2017

volume

146

1 reference

3 December 2017

issue

2

1 reference

3 December 2017

page(s)

291-297

1 reference

Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators.

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900171-6

Neurohormonal activation in severe heart failure: relations to patient death and the effect of treatment with flosequinan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900171-6

The oxidative stress hypothesis of congestive heart failure: radical thoughts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900171-6

Prognostic importance of the oxidized product of catecholamines, adrenolutin, in patients with severe heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900171-6

A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900171-6

Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900171-6

Chronic renal and neurohumoral effects of the calcium entry blocker nisoldipine in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900171-6

Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900171-6

Membrane antioxidant effects of the charged dihydropyridine calcium antagonist amlodipine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900171-6

Measurement of adrenolutin as an oxidation product of catecholamines in plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900171-6

Increased malondialdehyde in peripheral blood of patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900171-6

Oxidative stress is related to exercise intolerance in patients with heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900171-6

Increased oxidative stress in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900171-6

N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900171-6

Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900171-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900171-6

Changes in vasoconstrictive hormones, natriuretic peptides, and left ventricular remodeling soon after anterior myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900171-6

High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900171-6

Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900171-6

Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900171-6

ACE inhibitor co-therapy in patients with heart failure: rationale for the Randomized Aldactone Evaluation Study (RALES)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900171-6

Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900171-6

Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900171-6

10.1016/S0002-8703(03)00171-6

7 January 2021

Identifiers

DOI

1 reference

3 December 2017

1 reference